Expression immunohistochimique de l'endothéline-1 sur biopsies prostatiques : marqueur pronostique d'adénocarcinome localement avancé ?

Endothelin-1 (ET-1) prostate cancer biopsy expression in our study was an independent prognostic factor of extracapsular stage (pT3a). Further studies will assess the relevance of ET-1 expression study in clinically localised PCa for active surveillance, curative treatment or targeted adjuvant therapy management.